Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study - Top-Institutions - MDSpire

Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study

  • By

  • Raymond N Kuo

  • Wanchi Chen

  • Wen-Yi Shau

  • Shan-Chwen Chang

  • September 2, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Taiwan University Hospital
    National Taiwan University Hospital

    Taipei, Taiwan

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Clinical Pharmacology
  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Pharmacology
  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Trials
    • Pharmacology
  • #4

    University of Oxford
    University of Oxford

    Oxford, United Kingdom

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Pharmacology
  • #5

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Public Health
    • Epidemiology
    • Infectious Diseases

Original Source(s)

Related Content